COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,358 Articles (22,803 medRxiv, 8,555 bioRxiv)

Most recent first Previous |  Page 1038: Articles 10371-10380  | Next

Structural and functional characterizations of altered infectivity and immune evasion of SARS-CoV-2 Omicron variant
Cui, Z., Liu, P., Wang, N., Wang, L., Fan, K., Zhu, Q., Wang, K., Chen, R., Feng, R., Jia, Z., Yang, M., Zhu, B., Fu, W., Chu, T., Feng, L., Wang, Y., Pei, X., Yang, P., Xie, X. S., Cao, L., Cao, Y. R., Wang, X.
10.1101/2021.12.29.474402 — Posted: 2021-12-30
Forecasting COVID-19 infection trends and new hospital admissions in England due to SARS-CoV-2 Variant of Concern Omicron
Gerli, A. G., Centanni, S., Soriano, J. B., Ancochea, J.
10.1101/2021.12.29.21268521 — Posted: 2021-12-30
Short-term Projections based on Early Omicron Variant Dynamics in England.
Keeling, M. J., Brooks-Pollock, E., Challen, R. J., Danon, L., Dyson, L., Gog, J. R., Guzman-Rincon, L., Hill, E. M., Pellis, L. M., Read, J. M., Tildesley, M.
10.1101/2021.12.30.21268307 — Posted: 2021-12-30
The rich-to-poor vaccine donation game: When will self-interested countries donate their surplus vaccines during pandemics?
Lampert, A., Sulitzeanu-Kenan, R., Vanhuysse, P., Tepe, M.
10.1101/2021.12.30.21268537 — Posted: 2021-12-30 Discussion: Onsite
Reduced infectivity but increased immune escape of the new SARS-CoV-2 variant of concern Omicron
Hu, J., Peng, P., Wu, K., Long, Q.-x., Chen, J., Wang, K., Tang, N., Huang, A.-l.
10.1101/2021.12.24.474110 — Posted: 2021-12-30
Effectiveness of casirivimab and imdevimab, and sotrovimab during Delta variant surge: a prospective cohort study and comparative effectiveness randomized trial
Huang, D. T., McCreary, E. K., Bariola, J. R., Minnier, T. E., Wadas, R. J., Shovel, J. A., Albin, D., Marroquin, O. C., Kip, K. E., Collins, K., Schmidhofer, M., Wisniewski, M. K., Nace, D. A., Sullivan, C., Axe, M., Meyers, R., Weissman, A., Garrard, W., Peck-Palmer, O. M., Wells, A., Bart, R. D., Yang, A., Berry, L. R., Berry, S., Crawford, A. M., McGlothlin, A., Khadem, T., Linstrum, K., Montgomery, S. K., Ricketts, D., Kennedy, J. N., Pidro, C. J., Zapf, R. L., Kip, P. L., Haidar, G., Snyder, G. M., McVerry, B. J., Yealy, D. M., Angus, D. C., Seymour, C. W.
10.1101/2021.12.23.21268244 — Posted: 2021-12-30
Homologous or Heterologous Booster of Inactivated Vaccine Reduces SARS-CoV-2 Omicron Variant Escape from Neutralizing Antibodies
Wang, X., Zhao, X., Song, J., Wu, J., Zhu, Y., Li, M., Cui, Y., Chen, Y., Yang, L., Liu, J., Zhu, H., Jiang, S., Wang, P.
10.1101/2021.12.24.474138 — Posted: 2021-12-30
Preserved Omicron Spike specific antibody binding and Fc-recognition across COVID-19 vaccine platforms
Bartsch, Y., Tong, X., Kang, J., Avendano, M. J., Serrano, E. F., Garcia-Salum, T., Pardo-Roa, C., Riquelme, A., Medina, R. A., Alter, G.
10.1101/2021.12.24.21268378 — Posted: 2021-12-30
Seroprevalence, waning, and correlates of anti-SARS-CoV-2 IgG antibodies in Tyrol, Austria: Large-scale study of 35,193 blood donors conducted between June 2020 and September 2021
Siller, A., Seekircher, L., Wachter, G. A., Astl, M., Tschiderer, L., Pfeifer, B., Gaber, M., Schennach, H., Willeit, P.
10.1101/2021.12.27.21268456 — Posted: 2021-12-29
Real-time Estimation of Global CFR Ascribed to COVID-19 Confirmed Cases Applying Machine Learning Technique
PATTNAIK, M., PATTNAIK, A.
10.1101/2021.12.27.21268463 — Posted: 2021-12-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).